Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Other Non-Current Liabilities (2016 - 2025)

STRATA Skin Sciences' Other Non-Current Liabilities history spans 13 years, with the latest figure at $264000.0 for Q2 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 44.19% to $264000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $264000.0, a 44.19% decrease, with the full-year FY2024 number at $353000.0, down 68.9% from a year prior.
  • Other Non-Current Liabilities hit $264000.0 in Q2 2025 for STRATA Skin Sciences, down from $292000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for SSKN hit a ceiling of $8.6 million in Q2 2022 and a floor of $24000.0 in Q1 2021.
  • Historically, Other Non-Current Liabilities has averaged $1.9 million across 5 years, with a median of $379000.0 in 2024.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 17495.92% in 2022 and later tumbled 94.01% in 2024.
  • Tracing SSKN's Other Non-Current Liabilities over 5 years: stood at $428000.0 in 2021, then surged by 1841.36% to $8.3 million in 2022, then crashed by 86.34% to $1.1 million in 2023, then crashed by 68.9% to $353000.0 in 2024, then decreased by 25.21% to $264000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for SSKN at $264000.0 in Q2 2025, $292000.0 in Q1 2025, and $353000.0 in Q4 2024.